Authors: KNEER J LEUDIN E LESSLAUER W BIRNBOECK H STEVENS RM

Citation: J. Kneer et al., ANASSESSMENT OF THE EFFECT OF ANTI-DRUG ANTIBODY-FORMATION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF STNFR55-IGG (RO 45-2081-LENERCEPT [LEN]) (S.C.) IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 41(9), 1998, pp. 155-155

Authors: WEBER C SCHMITT R BIRNBOECK H HOPFGARTNER G VANMARLE SP PEETERS PAM JONKMAN JHG JONES CR

Citation: C. Weber et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ENDOTHELIN-RECEPTOR ANTAGONIST BOSENTAN IN HEALTHY-HUMAN SUBJECTS, Clinical pharmacology and therapeutics, 60(2), 1996, pp. 124-137

Authors: GUENTERT TW GRANGE S BOCK J WALDBURGER R BIRNBOECK H HOFFMANNLAROCHE F

Citation: Tw. Guentert et al., LACK OF AN IMPORTANT INFLUENCE OF CYP2D6 OXIDATION STATUS ON THE PHARMACOKINETICS OF MOCLOBEMIDE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 151-151